136 related articles for article (PubMed ID: 37580867)
1. Antenatal Neuroprotective Magnesium Sulfate in Very Preterm Infants and Its Association With Feeding Intolerance.
Ozer Bekmez B; Kanmaz Kutman HG; Oguz Y; Uygur D; Elbayiyev S; Canpolat FE; Oguz SS; Tayman C
J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):597-602. PubMed ID: 37580867
[TBL] [Abstract][Full Text] [Related]
2. Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.
Stark MJ; Hodyl NA; Andersen CC
Pediatr Res; 2015 Sep; 78(3):310-4. PubMed ID: 25985294
[TBL] [Abstract][Full Text] [Related]
3. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
4. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
[TBL] [Abstract][Full Text] [Related]
5. Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.
De Jesus LC; Sood BG; Shankaran S; Kendrick D; Das A; Bell EF; Stoll BJ; Laptook AR; Walsh MC; Carlo WA; Sanchez PJ; Van Meurs KP; Bara R; Hale EC; Newman NS; Ball MB; Higgins RD;
Am J Obstet Gynecol; 2015 Jan; 212(1):94.e1-7. PubMed ID: 25046806
[TBL] [Abstract][Full Text] [Related]
6. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
[TBL] [Abstract][Full Text] [Related]
7. Effects of Maternal Magnesium Sulfate Treatment on Neonatal Feeding Tolerance.
Belden MK; Gnadt S; Ebert A
J Pediatr Pharmacol Ther; 2017; 22(2):112-117. PubMed ID: 28469536
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects.
Paradisis M; Osborn DA; Evans N; Kluckow M
J Perinatol; 2012 Sep; 32(9):665-70. PubMed ID: 22094492
[TBL] [Abstract][Full Text] [Related]
9. Feed intolerance in preterm neonates with antenatal reverse end diastolic flow (REDF) in umbilical artery: a retrospective cohort study.
Aradhya AS; Mukhopadhyay K; Saini SS; Sundaram V; Dutta S; Kumar P
J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1846-1852. PubMed ID: 30373425
[No Abstract] [Full Text] [Related]
10. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
11. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
12. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
[TBL] [Abstract][Full Text] [Related]
13. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Faucett AM; Metz TD; DeWitt PE; Gibbs RS
Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Antenatal Magnesium Sulfate for Neuroprotection in Extreme Prematurity: A Comparative Observational Study.
Bansal V; Desai A
J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):36-47. PubMed ID: 34393393
[TBL] [Abstract][Full Text] [Related]
15. Early versus delayed minimal enteral feeding and risk for necrotizing enterocolitis in preterm growth-restricted infants with abnormal antenatal Doppler results.
Karagianni P; Briana DD; Mitsiakos G; Elias A; Theodoridis T; Chatziioannidis E; Kyriakidou M; Nikolaidis N
Am J Perinatol; 2010 May; 27(5):367-73. PubMed ID: 20013579
[TBL] [Abstract][Full Text] [Related]
16. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage.
Mittendorf R; Dambrosia J; Dammann O; Pryde PG; Lee KS; Ben-Ami TE; Yousefzadeh D
J Pediatr; 2002 May; 140(5):540-6. PubMed ID: 12032519
[TBL] [Abstract][Full Text] [Related]
17. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
Battarbee AN; Ros ST; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Andrews W; Saade G; Sadovsky Y; Reddy UM; Varner MW; Manuck TA;
Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100077. PubMed ID: 32905377
[TBL] [Abstract][Full Text] [Related]
19. Effects of Antenatal Magnesium Sulfate on the Gut Function of Preterm (<32 weeks) Very Low Birth Weight Neonates: Experience from a Tertiary Institute in South India.
Chandran S; Tergestina M; Ross B; Joshi A; Rebekah G; Kumar M
J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34100090
[TBL] [Abstract][Full Text] [Related]
20. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
